| 1RWK | B:317-400; B:317-400 | CRYSTAL STRUCTURE OF HUMAN CASPASE-1 IN COMPLEX WITH 3-(2-MERCAPTO-ACETYLAMINO)-4-OXO-PENTANOIC ACID |
| 1RWM | B:317-400; B:317-400 | CRYSTAL STRUCTURE OF HUMAN CASPASE-1 IN COMPLEX WITH 4-OXO-3-[2-(5-{[4-(QUINOXALIN-2-YLAMINO)-BENZOYLAMINO]-METHYL}-THIOPHEN-2-YL)-ACETYLAMINO]-PENTANOIC ACID |
| 1RWN | B:317-400; B:317-400 | CRYSTAL STRUCTURE OF HUMAN CASPASE-1 IN COMPLEX WITH 3-{2-ETHYL-6-[4-(QUINOXALIN-2-YLAMINO)-BENZOYLAMINO]-HEXANOYLAMINO}-4-OXO-BUTYRIC ACID |
| 1RWP | B:317-400; B:317-400 | CRYSTAL STRUCTURE OF HUMAN CASPASE-1 IN COMPLEX WITH 3-{6-[(8-HYDROXY-QUINOLINE-2-CARBONYL)-AMINO]-2-THIOPHEN-2-YL-HEXANOYLAMINO}-4-OXO-BUTYRIC ACID |
| 1RWV | B:317-400; B:317-400 | CRYSTAL STRUCTURE OF HUMAN CASPASE-1 IN COMPLEX WITH 5-[5-(1-CARBOXYMETHYL-2-OXO-PROPYLCARBAMOYL)-5-PHENYL-PENTYLSULFAMOYL]-2-HYDROXY-BENZOIC ACID |
| 1RWW | B:317-400; B:317-400 | CRYSTAL STRUCTURE OF HUMAN CASPASE-1 IN COMPLEX WITH 4-OXO-3-[(6-{[4-(QUINOXALIN-2-YLAMINO)-BENZOYLAMINO]-METHYL}-PYRIDINE-3-CARBONYL)-AMINO]-BUTYRIC ACID |
| 1RWX | B:317-400; B:317-400 | CRYSTAL STRUCTURE OF HUMAN CASPASE-1 IN COMPLEX WITH 4-OXO-3-{6-[4-(QUINOXALIN-2-YLOXY)-BENZOYLAMINO]-2-THIOPHEN-2-YL-HEXANOYLAMINO}-BUTYRIC ACID |
| 1SC1 | B:317-400; B:317-400 | CRYSTAL STRUCTURE OF AN ACTIVE-SITE LIGAND-FREE FORM OF THE HUMAN CASPASE-1 C285A MUTANT |
| 1SC3 | B:317-400; B:317-400 | CRYSTAL STRUCTURE OF THE HUMAN CASPASE-1 C285A MUTANT IN COMPLEX WITH MALONATE |
| 1PYO | D:207-298; D:207-298; D:207-298; D:207-298 | CRYSTAL STRUCTURE OF HUMAN CASPASE-2 IN COMPLEX WITH ACETYL-LEU-ASP-GLU-SER-ASP-CHO |
| 2P2C | L:211-298; L:211-298; L:211-298; L:211-298; L:211-298; L:211-298; L:211-298; L:211-298; L:211-298; L:211-298; L:211-298; L:211-298 | INHIBITION OF CASPASE-2 BY A DESIGNED ANKYRIN REPEAT PROTEIN (DARPIN) |
| 1NME | B:186-275; B:186-275 | STRUCTURE OF CASP-3 WITH TETHERED SALICYLATE |
| 1NMQ | B:45-275; B:45-275 | EXTENDEND TETHERING: IN SITU ASSEMBLY OF INHIBITORS |
| 1NMS | B:45-275; B:45-275 | CASPASE-3 TETHERED TO IRREVERSIBLE INHIBITOR |
| 1PAU | B:320-400; B:320-400 | CRYSTAL STRUCTURE OF THE COMPLEX OF APOPAIN WITH THE TETRAPEPTIDE ALDEHYDE INHIBITOR AC-DEVD-CHO |
| 1QX3 | A:45-275 | CONFORMATIONAL RESTRICTIONS IN THE ACTIVE SITE OF UNLIGANDED HUMAN CASPASE-3 |
| 1RE1 | B:320-400; B:320-400 | CRYSTAL STRUCTURE OF CASPASE-3 WITH A NICOTINIC ACID ALDEHYDE INHIBITOR |
| 1RHJ | D:820-900; D:820-900; D:820-900; D:820-900 | CRYSTAL STRUCTURE OF THE COMPLEX OF CASPASE-3 WITH A PRYAZINONE INHIBITOR |
| 1RHK | B:320-400; B:320-400 | CRYSTAL STRUCTURE OF THE COMPLEX OF CASPASE-3 WITH A PHENYL-PROPYL-KETONE INHIBITOR |
| 1RHM | D:820-900; D:820-900; D:820-900; D:820-900 | CRYSTAL STRUCTURE OF THE COMPLEX OF CASPASE-3 WITH A NICOTINIC ACID ALDEHYDE INHIBITOR |
| 1RHQ | E:320-400; E:320-400; E:320-400; E:320-400 | CRYSTAL STRUCTURE OF THE COMPLEX OF CASPASE-3 WITH A BROMOMETHOXYPHENYL INHIBITOR |
| 1RHR | B:320-400; B:320-400 | CRYSTAL STRUCTURE OF THE COMPLEX OF CASPASE-3 WITH A CINNAMIC ACID METHYL ESTER INHIBITOR |
| 1RHU | B:320-400; B:320-400 | CRYSTAL STRUCTURE OF THE COMPLEX OF CASPASE-3 WITH A 5,6,7 TRICYCLIC PEPTIDOMIMETIC INHIBITOR |
| 3KJF | B:176-275; B:176-275 | CASPASE 3 BOUND TO A COVALENT INHIBITOR |
| 3PCX | A:45-275 | CASPASE-3 E246A, K242A DOUBLE MUTANT |
| 3PD0 | A:45-275 | CASPASE-3 E246A |
| 3PD1 | A:45-275 | CASPASE-3 K242A |
| 2WDP | D:45-288; D:45-288; D:45-288; D:45-288 | CRYSTAL STRUCTURE OF LIGAND FREE HUMAN CASPASE-6 |
| 3K7E | D:45-288; D:45-288; D:45-288; D:45-288 | CRYSTAL STRUCTURE OF HUMAN LIGAND-FREE MATURE CASPASE-6 |
| 3NKF | D:45-288; D:45-288; D:45-288; D:45-288 | CRYSTAL STRUCTURE OF HUMAN LIGAND-FREE MATURE CASPASE-6 WITH INTERSUBUNIT LINKER ATTACHED |
| 3NR2 | B:45-288; B:45-288 | CRYSTAL STRUCTURE OF CASPASE-6 ZYMOGEN |
| 3OD5 | B:45-288; B:45-288 | CRYSTAL STRUCTURE OF ACTIVE CASPASE-6 BOUND WITH AC-VEID-CHO |
| 3P45 | P:201-288; P:201-288; P:201-288; P:201-288; P:201-288; P:201-288; P:201-288; P:201-288; P:201-288; P:201-288; P:201-288; P:201-288; P:201-288; P:201-288; P:201-288; P:201-288 | CRYSTAL STRUCTURE OF APO-CASPASE-6 AT PHYSIOLOGICAL PH |
| 1K86 | B:68-301; B:68-301 | CRYSTAL STRUCTURE OF CASPASE-7 |
| 1K88 | B:68-301; B:68-301 | CRYSTAL STRUCTURE OF PROCASPASE-7 |
| 1KMC | B:163-400; B:163-400 | CRYSTAL STRUCTURE OF THE CASPASE-7 / XIAP-BIR2 COMPLEX |
| 1SHJ | B:68-301; B:68-301 | CASPASE-7 IN COMPLEX WITH DICA ALLOSTERIC INHIBITOR |
| 1SHL | B:68-301; B:68-301 | CASPASE-7 IN COMPLEX WITH FICA ALLOSTERIC INHIBITOR |
| 2QL7 | D:512-601; D:512-601; D:512-601; D:512-601 | CRYSTAL STRUCTURE OF CASPASE-7 WITH INHIBITOR AC-IEPD-CHO |
| 2QL9 | D:512-601; D:512-601; D:512-601; D:512-601 | CRYSTAL STRUCTURE OF CASPASE-7 WITH INHIBITOR AC-DQMD-CHO |
| 2QLB | D:512-601; D:512-601; D:512-601; D:512-601 | CRYSTAL STRUCTURE OF CASPASE-7 WITH INHIBITOR AC-ESMD-CHO |
| 2QLF | D:511-601; D:511-601; D:511-601; D:511-601 | CRYSTAL STRUCTURE OF CASPASE-7 WITH INHIBITOR AC-DNLD-CHO |
| 2QLJ | D:511-601; D:511-601; D:511-601; D:511-601 | CRYSTAL STRUCTURE OF CASPASE-7 WITH INHIBITOR AC-WEHD-CHO |
| 3R5K | B:368-601; B:368-601 | A DESIGNED REDOX-CONTROLLED CASPASE-7 |
| 1QDU | L:318-400; L:318-400; L:318-400; L:318-400; L:318-400; L:318-400; L:318-400; L:318-400; L:318-400; L:318-400; L:318-400; L:318-400 | CRYSTAL STRUCTURE OF THE COMPLEX OF CASPASE-8 WITH THE TRIPEPTIDE KETONE INHIBITOR ZEVD-DCBMK |
| 1QTN | B:390-476; B:390-476 | CRYSTAL STRUCTURE OF THE COMPLEX OF CASPASE-8 WITH THE TETRAPEPTIDE INHIBITOR ACE-IETD-ALDEHYDE |
| 2K7Z | A:234-476 | SOLUTION STRUCTURE OF THE CATALYTIC DOMAIN OF PROCASPASE-8 |
| 3KJN | B:390-476; B:390-476 | CASPASE 8 BOUND TO A COVALENT INHIBITOR |
| 3KJQ | B:390-476; B:390-476 | CASPASE 8 WITH COVALENT INHIBITOR |
| 1JXQ | D:163-400; D:163-400; D:163-400; D:163-400 | STRUCTURE OF CLEAVED, CARD DOMAIN DELETED CASPASE-9 |
| 1NW9 | B:161-413 | STRUCTURE OF CASPASE-9 IN AN INHIBITORY COMPLEX WITH XIAP-BIR3 |
)
)